GENEDX HOLDINGS (WGS)
(Delayed Data from NSDQ)
$34.22 USD
+2.93 (9.36%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $34.24 +0.02 (0.06%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum D VGM
Balance Sheet
Fiscal Year End for GeneDx Holdings Corp falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 130 | 137 | 401 | 1 | 0 |
Receivables | 33 | 43 | 27 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 9 | 14 | 33 | 0 | 0 |
Other Current Assets | 11 | 18 | 23 | 0 | 0 |
Total Current Assets | 182 | 213 | 484 | 1 | 0 |
Net Property & Equipment | 32 | 52 | 63 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 443 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 173 | 187 | 0 | 0 | 0 |
Deposits & Other Assets | 4 | 7 | 8 | 0 | 0 |
Total Assets | 419 | 491 | 554 | 444 | 0 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 37 | 46 | 45 | 0 | 0 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 3 | 0 | 0 |
Accrued Expenses | 0 | 39 | 20 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 18 | 53 | 33 | 0 | 0 |
Total Current Liabilities | 59 | 144 | 101 | 0 | 0 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 2 | 3 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 53 | 6 | 11 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 18 | 0 | 0 |
Other Non-Current Liabilities | 15 | 24 | 35 | 439 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 191 | 237 | 166 | 439 | 0 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,528 | 1,378 | 964 | 5 | 0 |
Retained Earnings | -1,300 | -1,124 | -575 | 0 | 0 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 228 | 254 | 388 | 5 | 0 |
Total Liabilities & Shareholder's Equity | 419 | 491 | 554 | 444 | 0 |
Total Common Equity | 228 | 254 | 388 | 5 | 0 |
Shares Outstanding | 25.90 | 11.70 | 7.30 | 1.60 | NA |
Book Value Per Share | 8.80 | 21.68 | 53.16 | 3.13 | 0.00 |
Fiscal Year End for GeneDx Holdings Corp falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 113 | 130 | 114 | 157 |
Receivables | NA | 29 | 33 | 32 | 34 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 12 | 9 | 9 | 12 |
Other Current Assets | NA | 10 | 11 | 16 | 11 |
Total Current Assets | NA | 163 | 182 | 172 | 213 |
Net Property & Equipment | NA | 31 | 32 | 36 | 43 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 169 | 173 | 176 | 180 |
Deposits & Other Assets | NA | 4 | 4 | 6 | 6 |
Total Assets | NA | 395 | 419 | 417 | 476 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 32 | 37 | 39 | 55 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 14 | 18 | 26 | 24 |
Total Current Liabilities | NA | 51 | 59 | 68 | 84 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 1 | 2 | 2 | 2 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 52 | 53 | 6 | 6 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 15 | 23 | 24 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 187 | 191 | 163 | 180 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 1,527 | 1,528 | 1,529 | 1,528 |
Retained Earnings | NA | -1,320 | -1,300 | -1,274 | -1,232 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 207 | 228 | 254 | 296 |
Total Liabilities & Shareholder's Equity | NA | 395 | 419 | 417 | 476 |
Total Common Equity | 0 | 207 | 228 | 254 | 296 |
Shares Outstanding | 26.10 | 26.10 | 25.90 | 25.80 | 25.70 |
Book Value Per Share | 0.00 | 7.94 | 8.80 | 9.86 | 11.52 |